How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

27,330 results for

IV Access

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Testing for epidermal growth factor receptor (EGFR) status in patients with locally advanced (stage IIIB) or metastatic (stage IV) non-small cell lung cancer (NSCLC) for access to erlotinib

Testing for epidermal growth factor receptor (EGFR) status in patients with locally advanced (stage IIIB) or metastatic (stage IV) non-small cell lung cancer (NSCLC) for access to erlotinib 1/15 Public Summary Document Application No. 1173 – Testing for epidermal growth factor receptor (EGFR) status in patients with locally advanced (stage IIIB) or metastatic (stage IV) non-small cell lung cancer (NSCLC) for access to erlotinib Sponsor/Applicant/s: Roche Products Pty Ltd Date of MSAC (...) with locally advanced or metastatic non-small cell lung cancer’. EGFR testing for access to gefitinib in the second-line setting has been MBS listed since May 2012. Erlotinib was proposed for the first-line treatment of patients with advanced (stage IIIb) or metastatic (stage IV) NSCLC with activating epidermal growth factor receptor (EGFR) mutations in 2012. A co-dependent submission for public funding of erlotinib and the EGFR mutation test was considered by PBAC in July 2012 and MSAC in August 2012

2013 Medical Services Advisory Committee

2. Central venous catheter placement after ultrasound guided peripheral IV placement for difficult vascular access patients. (PubMed)

Central venous catheter placement after ultrasound guided peripheral IV placement for difficult vascular access patients. Ultrasound guided peripheral intravenous catheters (USPIV) are frequently utilized in the Emergency Department (ED) and lead to reduced central venous catheter (CVC) placements. USPIVs, however, are reported to have high failure rates. Our primary objective was to determine the proportion of patients that required CVC after USPIV. Our secondary objective was to determine (...) if classic risk factors for difficult vascular access were predictive of future CVC placement.We performed a retrospective review for patients treated at a large academic hospital. Patients were identified by electronic health record and were restricted to age older than 21 years, had received USPIV, and admittance. Exclusion criteria included an existing CVC. Descriptive statistics, t-tests, chi-square proportions, and logistic regression were performed to test associations.Of 363 eligible patients, 20

2018 American Journal of Emergency Medicine

3. Buzzy Use for IV Access

Buzzy Use for IV Access Effectiveness of External Vibration for Pain Relief During Intravenous Access in Adult Patients - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Effectiveness of External Vibration (...) attempt, if a smaller or larger gauge IV catheter is required, or if an insertion site not listed above is required. The case will be excluded if adjunctive steps are taken to obtain IV access (i.e. Oral sedation, nitrous oxide, heat packs). Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Actual Enrollment : 100 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Treatment Official

2018 Clinical Trials

4. Superior Venous Access, Midline vs Ultrasound IVs

Superior Venous Access, Midline vs Ultrasound IVs Superior Venous Access, Midline vs Ultrasound IVs - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Superior Venous Access, Midline vs Ultrasound IVs (...) Pare, Boston Medical Center Study Details Study Description Go to Brief Summary: Obtaining intravenous access (IVA) is the most common procedure performed in the emergency department (ED). Placement of IVA allows for blood work and delivery of intravenous fluids and medications. The implementation of ultrasound guided peripheral IVs (UGPIV) have allowed for ultrasound to be used to place an IV into patients with difficult vein access (DVA). An alternative device to place is a midline catheter (MC

2018 Clinical Trials

5. Ultrasound-guided Peripheral IV vs. Standard Technique in Difficult Vascular Access Patients by ICU Nurses

Ultrasound-guided Peripheral IV vs. Standard Technique in Difficult Vascular Access Patients by ICU Nurses Ultrasound-guided Peripheral IV vs. Standard Technique in Difficult Vascular Access Patients by ICU Nurses - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100 (...) ). Please remove one or more studies before adding more. Ultrasound-guided Peripheral IV vs. Standard Technique in Difficult Vascular Access Patients by ICU Nurses The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03745209

2018 Clinical Trials

6. Effect of Intravenous (IV) Assistive Device (VeinViewer) on IV Access Attempts, Procedural Time, and Patient and Nurse Satisfaction. (PubMed)

Effect of Intravenous (IV) Assistive Device (VeinViewer) on IV Access Attempts, Procedural Time, and Patient and Nurse Satisfaction. This study evaluated the effectiveness of VeinViewer for peripheral vascular accessing a pediatric hematology oncology clinic. After obtaining consent, 53 patients were randomly assigned to either the VeinViewer group (n = 27) or standard methods group (n = 26). Data on number of attempts, procedural time, access complications, and patient and nurse satisfaction (...) were collected. Patients randomized to the VeinViewer group required significantly less time to access a vein as compared with the standard methods group (P ≤ .05). Additionally, these patients rated nurses as having significantly more skill than nurses who did not use VeinViewer (P ≤ .05) and assigned significantly higher scores for "overall experience"(P ≤ .05). Responses by nurses using VeinViewer overall saw the device in a positive light. © 2015 by Association of Pediatric Hematology/Oncology

2016 Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses

7. Testing for epidermal growth factor receptor (EGFR) status in patients with locally advanced (stage IIIB) or metastatic (stage IV) non-small cell lung cancer (NSCLC) for access to erlotinib

Testing for epidermal growth factor receptor (EGFR) status in patients with locally advanced (stage IIIB) or metastatic (stage IV) non-small cell lung cancer (NSCLC) for access to erlotinib Testing for epidermal growth factor receptor (EGFR) status in patients with locally advanced (stage IIIB) or metastatic (stage IV) non-small cell lung cancer (NSCLC) for access to erlotinib Testing for epidermal growth factor receptor (EGFR) status in patients with locally advanced (stage IIIB) or metastatic (...) (stage IV) non-small cell lung cancer (NSCLC) for access to erlotinib Medical Services Advisory Committee Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Medical Services Advisory Committee. Testing for epidermal growth factor receptor (EGFR) status in patients with locally advanced (stage IIIB) or metastatic (stage IV) non-small cell lung cancer (NSCLC) for access

2013 Health Technology Assessment (HTA) Database.

8. Comparison Between Initial Routine PICC and General IV Access in Terminally Ill Cancer Patients

Comparison Between Initial Routine PICC and General IV Access in Terminally Ill Cancer Patients Comparison Between Initial Routine PICC and General IV Access in Terminally Ill Cancer Patients - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one (...) or more studies before adding more. Comparison Between Initial Routine PICC and General IV Access in Terminally Ill Cancer Patients The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03299868 Recruitment Status : Recruiting

2017 Clinical Trials

9. A Patient Navigation Program to Increase Access to Early Supportive Care in Patients With Stage IV Solid Tumors

A Patient Navigation Program to Increase Access to Early Supportive Care in Patients With Stage IV Solid Tumors A Patient Navigation Program to Increase Access to Early Supportive Care in Patients With Stage IV Solid Tumors - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved (...) studies (100). Please remove one or more studies before adding more. A Patient Navigation Program to Increase Access to Early Supportive Care in Patients With Stage IV Solid Tumors The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03293849 Recruitment Status : Active, not recruiting First Posted

2017 Clinical Trials

10. Access to treatment for Hepatitis C among injection drug users: results from the cross-sectional HOPE IV study (PubMed)

Access to treatment for Hepatitis C among injection drug users: results from the cross-sectional HOPE IV study Evidence suggests that Greece is among the European countries with increased trend in HCV prevalence among injecting drug users (IDUs) from 2008 to 2014. Nonetheless, the access of IDUs to treatment for Hepatitis C Virus (HCV) is very limited while the risk of co-infection and transmission remains high. In an effort to better understand the inhibitors to HCV treatment, the present (...) study aimed to investigate the main barriers to access in a sample of IDUs.The cross-sectional study was carried out between July and September 2015 using a 23-items questionnaire. Participants were recruited from urban primary services, mobile health vans, community health services, day-care centers as well as during street work, located in Athens, Greece. Inclusion criteria were age above 18 years, understanding and speaking Greek sufficiently, HCV diagnosis, intravenous drug use. Data collection

Full Text available with Trip Pro

2017 International journal for equity in health

11. IV Packs-Trolleys: Single versus more than one use

of the evidence on IV packs. The focus of the review investigated whether single versus multi-use IV packs impacted infection rates. Currently, when a pack is opened in preparation for an IV insertion and the inserter realizes they need to access a different cannula or other piece of IV equipment then the pack needs to be discarded and a new one opened. The purpose of this is review is to better understand the reusability of IV pack/trolley and the impact on infection rates as outlined in the scenario above (...) IV Packs-Trolleys: Single versus more than one use Rapid Literature Review 1 Rapid Literature Review IV Packs-Trolleys: Single versus more than one use Citation Fiona Clay & Angela Melder. 2018. IV Packs-Trolleys: Single versus more than one use Evidence Review. Centre for Clinical Effectiveness, Monash Health, Melbourne, Australia. Contact CCE@monashhealth.org Background Professor Carlos Scheinkestel, Executive Director, Quality, Safety and Patient Experience has requested CCE provide a review

2019 Monash Health Evidence Reviews

12. IV night teams: Impact on Infection rates, insertion success and deskilling

could lead to a reduction in IV associated infections at Monash Health without problems with deskilling. Objective To identify whether IV teams are associated with a decrease in infection rates, insertion success and an increase in deskilling. Summary of Findings We searched 7 peer reviewed databases and 8 grey literature databases. In addition we screened Google and Google Scholar and electronically searched two journals: Journal of Vascular Access and Journal of Infusion Nursing. We also contacted (...) two experts from the Avatar group (A research group specializing in highly credible scientific vascular access device research https://www.avatargroup.org.au/about-us.html). We were unable to find anything relevant in IV night teams despite the use of multiple databases and a range of search terms. What we did find: IV teams and infection rates: ? Intravenous catheters initiated by IV team compared to non-IV team indicates that infection rates and phlebitis are less when IV teams insert

2019 Monash Health Evidence Reviews

13. Expanded Access of Omegaven IV Fat Emulsion to Infants and Children With PNALD

Expanded Access of Omegaven IV Fat Emulsion to Infants and Children With PNALD Expanded Access of Omegaven IV Fat Emulsion to Infants and Children With PNALD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Expanded Access of Omegaven IV Fat Emulsion to Infants and Children With PNALD The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02929303 Expanded Access Status : Approved for marketing First Posted : October 11, 2016 Last Update Posted : February 19, 2019 Sponsor: Hector Hernandez Information provided

2016 Clinical Trials

14. Efficacy and safety of anti-epileptic drugs in patients with active convulsive seizures when no IV access is available: Systematic review and meta-analysis. (PubMed)

Efficacy and safety of anti-epileptic drugs in patients with active convulsive seizures when no IV access is available: Systematic review and meta-analysis. To explore the existing evidence for anti-convulsant drugs and their routes of administration in treating acute seizures in children and adults when intravenous access is not available.All major databases including Medline via Ovid, PubMed, Cochrane CENTRAL, Embase, and Google Scholar were searched till May 2015. Randomized and quasi (...) cessation after presentation (includes time for drug administration) was lower in the non-intravenous group. Significant adverse effects were infrequently reported and when present, were similar in both the groups.When intravenous access is not available, non-intravenous routes of administration of benzodiazepines should be considered for the control of acute seizures in children/adults. The preference may be guided by availability, expertise and social preference. [PROSPERO No: CRD42015019012

2016 Epilepsy research

15. Peripheral IV Access

Peripheral IV Access Peripheral IV Access Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Peripheral IV Access Peripheral IV Access (...) Aka: Peripheral IV Access , Peripheral Catheterization , Peripheral Venous Catheterization , Peripheral Intravenous Catheter , Peripheral Vascular Catheter II. Types: Needles Over the Needle Catheter (Preferred) Age < 1 year: 22, 24 gauges Age 1-8 years: 18, 20, 22 gauges Age >8 years: 16, 18, 20 gauges Large Bore: 14-16 gauge Butterfly Needle Newborn: 23-25 gauges Age <8 years: 23, 21, 20 gauges Age >8 years: 21, 20, 18 gauges III. Types: Sites Upper Extremity: Antecubital Cephalic Vein (lateral

2018 FP Notebook

16. Central IV Access

Central IV Access Central IV Access Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Central IV Access Central IV Access Aka: Central (...) IV Access , Central Line , Central Line Placement , Central Venous Cetheterization , Central Line Management II. Indications Medications causing tissue necrosis on extravasation or otherwise harmful via peripheral IV Large volume infusion required Unobtainable or unreliable Pulmonary artery pacing Invasive Monitoring s ( ) and oxygenation ( ) Left ventricular filling pressure (pulmonary artery catheter or wedge pressure) III. Preparation Perform under dynamic guidance Confirms vessel location

2018 FP Notebook

17. IV Access

IV Access IV Access Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 IV Access IV Access Aka: IV Access , Intravenous Access , Venous (...) Cannula Insertion II. Approach: Access Sites Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "IV Access." Click on the image (or right click) to open the source website in a new browser window. Related Studies (from Trip Database) Ontology: Venous cannula insertion (C0398266) Definition (PNDS) Establishes and maintains peripheral IV access to administer IV fluids, medications, and blood products per physician order. Concepts Health

2018 FP Notebook

18. Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease

Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before (...) adding more. Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02743806 Recruitment Status : Active, not recruiting First Posted : April 19, 2016 Last Update Posted : October 9, 2018 Sponsor: Takeda Information provided

2016 Clinical Trials

19. MutS regulates access of the error-prone DNA polymerase Pol IV to replication sites: a novel mechanism for maintaining replication fidelity (PubMed)

MutS regulates access of the error-prone DNA polymerase Pol IV to replication sites: a novel mechanism for maintaining replication fidelity Translesion DNA polymerases (Pol) function in the bypass of template lesions to relieve stalled replication forks but also display potentially deleterious mutagenic phenotypes that contribute to antibiotic resistance in bacteria and lead to human disease. Effective activity of these enzymes requires association with ring-shaped processivity factors, which (...) dictate their access to sites of DNA synthesis. Here, we show for the first time that the mismatch repair protein MutS plays a role in regulating access of the conserved Y-family Pol IV to replication sites. Our biochemical data reveals that MutS inhibits the interaction of Pol IV with the β clamp processivity factor by competing for binding to the ring. Moreover, the MutS-β clamp association is critical for controlling Pol IV mutagenic replication under normal growth conditions. Thus, our findings

Full Text available with Trip Pro

2016 Nucleic acids research

20. Heparin Flushing of IV Lines

of Peripheral IV Catheters in Children: A Systematic Review. Pediatrics; 131:e864–e872. 3. Takashima, M et al. (2015). Randomised controlled trials in peripheral vascular access catheters: a scoping review. Vascular Access, 10–37. 4. Upadhyay, A et al. (2015). Heparin for prolonging peripheral intravenous catheter use in neonates: a randomised controlled trial. Journal of Perinatology: 35, 274-277. 5. Arnts, IJJ et al. (2011). Effectiveness of heparin solution versus normal saline in maintaining patency (...) Heparin Flushing of IV Lines Rapid Review 1 Heparin flushing of IV lines Citation Centre for Clinical Effectiveness. 2017. Heparin flushing of IV lines: Rapid Review. Centre for Clinical Effectiveness, Monash Health, Melbourne, Australia. Executive Summary Background Monash Health are working on improving procedural and maintenance documentation as a result of the dramatic increase in the size of the lines service with the opening of the new Children’s Hospital. As part of this, they are re

2017 Monash Health Evidence Reviews

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>